EGFR , KRAS , BRAF , and HER ‐2 molecular status in brain metastases from 77 NSCLC patients-Reference-Cited by-同舟云学术

EGFR , KRAS , BRAF , and HER ‐2 molecular status in brain metastases from 77 NSCLC patients

Published:2013-04-23 Issue:3 Volume:2 Page:296-304
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Villalva Claire¹²,Duranton‐Tanneur Valérie³,Guilloteau Karline²,Burel‐Vandenbos Fanny⁴,Wager Michel⁵,Doyen Jérôme³,Levillain Pierre Marie⁶,Fontaine Denys⁷,Blons Hélène⁸⁹,Pedeutour Florence³¹⁰,Karayan‐Tapon Lucie¹²

Affiliation:

1. INSERM U935 Poitiers University Poitiers France

2. Laboratory of Molecular Oncology Poitiers University Hospital Poitiers France

3. Laboratory of Solid Tumors Genetics Faculty of Medicine Nice University Hospital Nice France

4. Central Department of Pathology Faculty of Medicine Nice University Hospital Nice France

5. Department of Neurosurgery Faculty of Medicine Poitiers University Hospital Poitiers France

6. Department of Pathology Poitiers University Hospital Poitiers France

7. Department of Neurosurgery Faculty of Medicine Nice University Hospital Nice France

8. Departement of Biology European Georges Pompidou Hospital AP‐HP Paris France

9. INSERMU775 Paris Descartes University Paris France

10. Institute of Research on Cancer and Ageing in Nice (IRCAN) Sophia‐Antipolis University Nice France

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.82

Reference47 articles.

1. High Risk of Brain Metastases in Surgically Staged IIIA Non–Small-Cell Lung Cancer Patients Treated With Surgery, Chemotherapy, and Radiation

2. Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: Correlation with survival

3. Prognosis of patients treated for intracranial metastases with whole-brain irradiation

4. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

5. Les métastases cérébrales des cancers bronchiques non à petites cellules : vers une prise en charge homogène

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing non-small cell lung cancer treatment: the power of combination immunotherapies;Frontiers in Immunology;2024-07-02

2. Prevention of Brain Metastases: A New Frontier;Cancers;2024-06-04

3. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy;Frontiers in Immunology;2024-01-12

4. KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing;Lung Cancer;2023-10

5. Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor;Journal of Pathology and Translational Medicine;2023-07-15